abstract |
The present disclosure relates generally to improved pharmaceutical compositions useful for treating diseases and disorders. More specifically, the disclosure relates to pharmaceutical compositions for the treatment of neurodegenerative disorders and peripheral diseases comprising glyceryl tribenzoate and/or glyceryl dibenzoate. [Selection figure] None |